Get the Stockscreener App
2.23
4.69%
0.10
After Hours:
2.28
0.05
+2.24%
Treace Medical Concepts Inc stock is traded at $2.23, with a volume of 772.58K.
It is up +4.69% in the last 24 hours and up +52.74% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
See More
Previous Close:
$2.13
Open:
$2.16
24h Volume:
772.58K
Relative Volume:
0.89
Market Cap:
$144.47M
Revenue:
$212.69M
Net Income/Loss:
$-59.00M
P/E Ratio:
-2.3883
EPS:
-0.9337
Net Cash Flow:
$-29.49M
1W Performance:
+59.29%
1M Performance:
+52.74%
6M Performance:
-63.56%
1Y Performance:
-66.31%
1-Day Range:
$2.075
$2.2999
1-Week Range:
$1.315
$2.2999
52-Week Range:
$1.17
$7.78
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
2.23 | 137.99M | 212.69M | -59.00M | -29.49M | -0.9337 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-25 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-07-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
TMCI Faces Ownership Changes: Market Reactions Unclear - StocksToTrade
Treace Medical Concepts (TMCI) price target increased by 12.28% to 4.08 - MSN
US Stocks Mixed; Dow Falls Over 100 Points - Sahm
Wall Street Zen Upgrades Treace Medical Concepts (NASDAQ:TMCI) to Sell - MarketBeat
Chart Watch: Will Treace Medical Concepts Inc outperform tech stocksMarket Performance Report & Verified Momentum Stock Ideas - baoquankhu1.vn
Treace Medical Concepts Announces Leadership Transition and Outlook - The Globe and Mail
Stifel maintains Hold on Treace Medical stock, $3 target unchanged By Investing.com - Investing.com India
Stifel maintains Hold on Treace Medical stock, $3 target unchanged - Investing.com
Market Overview: Will Treace Medical Concepts Inc stock hit new highs in YEARPortfolio Risk Report & Long Hold Capital Preservation Tips - baoquankhu1.vn
Treace Medical Concepts, Inc. Reports Q1 2026 Results and Financial Outlook in SEC Form 8-K Filing 10 - Minichart
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 earnings call transcript - MSN
Treace Medical Concepts Incpreliminary Q1 2026 revenue expected at $47.0 million-$47.2 millionSEC filing - marketscreener.com
Treace Medical (NASDAQ: TMCI) raises 2026 sales view as CCO departs - Stock Titan
Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System - Ortho Spine News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) stock price, news, quote and history - Yahoo Finance UK
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat
Treace Medical Concepts, Inc. Announces First Surgical Cases With The SuperBite Compression Screw System - marketscreener.com
Treace Announces First Surgical Cases with the SuperBite Compression Screw System - Bitget
New foot-and-ankle screw reaches first surgeries before Q3 launch - Stock Titan
Treace Medical Concepts (NASDAQ:TMCI) and PAVmed (NASDAQ:PAVM) Head-To-Head Survey - Defense World
Movement Recap: Is Treace Medical Concepts Inc forming bullish engulfing patterns2026 PostEarnings & Reliable Breakout Forecasts - baoquankhu1.vn
Update Report: How much upside does Treace Medical Concepts Inc haveWeekly Investment Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts (NASDAQ: TMCI) details 2026 virtual annual meeting, votes - Stock Titan
[ARS] TREACE MEDICAL CONCEPTS, INC. SEC Filing - Stock Titan
TMCI PE Ratio & Valuation, Is TMCI Overvalued - Intellectia AI
Treace Medical Concepts (TMCI) price target decreased by 10.94% to 3.63 - MSN
CFO at Treace Medical (TMCI) granted 100,000 performance stock units - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect - ACCESS Newswire
Value Recap: How correlated is Treace Medical Concepts Inc to the S P5002026 AllTime Highs & Weekly High Return Stock Opportunities - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
TMCI Should I Buy - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect - ACCESS Newswire
2026-03-22 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect | NDAQ:TMCI | Press Release - Stockhouse
How The Story Is Shifting For Treace Medical Concepts (TMCI) After Analyst Target Resets - Yahoo Finance
Quarterly Earnings: Is Treace Medical Concepts Inc gaining market shareWeekly Trading Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
CIBC Bancorp USA Inc. Acquires New Stake in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $4.77 Average PT from Analysts - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI)June 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Treace Medical Concepts, Inc.Common Stock (NQ: TMCI - The Chronicle-Journal
How Treace Medical Concepts Inc. (TMCI) Affects Rotational Strategy Timing - Stock Traders Daily
Resistance Check: Is Treace Medical Concepts Inc gaining market shareMarket Trend Summary & Technical Buy Zone Confirmations - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Treace Medical (TMCI) legal chief reports routine tax share withholding - Stock Titan
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Treace Medical Concepts Inc Stock (TMCI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Scanlan Sean F. | Chief Innovation Officer |
Jan 21 '26 |
Option Exercise |
0.72 |
53,500 |
38,520 |
427,099 |
| Scanlan Sean F. | Chief Innovation Officer |
Jul 18 '25 |
Option Exercise |
0.72 |
33,437 |
24,001 |
383,621 |
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):